Home Page
Trending Articles
-
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med. 2023. PMID: 37952131
-
Structural and signaling mechanisms of TAAR1 enabled preferential agonist design.
Cell. 2023. PMID: 37963465
-
Rethinking how development assistance for health can catalyse progress on primary health care.
Lancet. 2023. PMID: 37967568 Review.